NO20005321L - Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette - Google Patents

Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette

Info

Publication number
NO20005321L
NO20005321L NO20005321A NO20005321A NO20005321L NO 20005321 L NO20005321 L NO 20005321L NO 20005321 A NO20005321 A NO 20005321A NO 20005321 A NO20005321 A NO 20005321A NO 20005321 L NO20005321 L NO 20005321L
Authority
NO
Norway
Prior art keywords
marek
disease
mdv
antibodies
host
Prior art date
Application number
NO20005321A
Other languages
English (en)
Other versions
NO20005321D0 (no
Inventor
Shane Campbell Burgess
Thornton Frederick Davison
Louis Joseph Norman Ross
Original Assignee
Inst Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Animal Health Ltd filed Critical Inst Animal Health Ltd
Publication of NO20005321D0 publication Critical patent/NO20005321D0/no
Publication of NO20005321L publication Critical patent/NO20005321L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

NukJein- og aminosyre-sekvenser som koder for et anti-gen som assosieres med fjærfe-svulster, særlig fjærfe-svulster som assosieres med Mareks sykdomssvirus. Oppfinnelsen angår videre bruk av sekvensene innen medisin, særlig ved produksjon av blandinger som er nyttige ved behandling og forebygging av fjærfe-svulster.
NO20005321A 1998-04-29 2000-10-23 Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette NO20005321L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809070.7A GB9809070D0 (en) 1998-04-29 1998-04-29 Biological material and uses thereof
PCT/GB1999/001238 WO1999055860A1 (en) 1998-04-29 1999-04-22 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto

Publications (2)

Publication Number Publication Date
NO20005321D0 NO20005321D0 (no) 2000-10-23
NO20005321L true NO20005321L (no) 2000-12-20

Family

ID=10831122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005321A NO20005321L (no) 1998-04-29 2000-10-23 Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette

Country Status (8)

Country Link
EP (1) EP1073735A1 (no)
JP (1) JP2002518995A (no)
CN (1) CN1307638A (no)
AU (1) AU3618099A (no)
CA (1) CA2327178A1 (no)
GB (1) GB9809070D0 (no)
NO (1) NO20005321L (no)
WO (1) WO1999055860A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107090438B (zh) * 2017-05-16 2021-01-01 中国农业科学院哈尔滨兽医研究所 抗血清I型MDV gI蛋白的单克隆抗体、分泌该抗体的杂交瘤细胞株及其应用
JP7760161B2 (ja) * 2021-06-08 2025-10-27 国立研究開発法人農業・食品産業技術総合研究機構 マレック病ウイルスＭｅｑタンパク質に対する抗体
CN114540312B (zh) * 2022-03-16 2023-03-24 河南省农业科学院 一种血清1型马立克病病毒pp38单克隆抗体的制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0837929A2 (en) * 1995-07-07 1998-04-29 Nippon Zeon Co., Ltd. Marek's disease virus genes and their use in vaccines for protection against marek's disease

Also Published As

Publication number Publication date
AU3618099A (en) 1999-11-16
CN1307638A (zh) 2001-08-08
CA2327178A1 (en) 1999-11-04
EP1073735A1 (en) 2001-02-07
JP2002518995A (ja) 2002-07-02
GB9809070D0 (en) 1998-06-24
WO1999055860A1 (en) 1999-11-04
WO1999055860A8 (en) 2001-10-04
NO20005321D0 (no) 2000-10-23

Similar Documents

Publication Publication Date Title
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NO20013701D0 (no) HER-2/neu-fusjonsproteiner
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
WO1996010419A3 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
DE3751751D1 (de) Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
ATE411043T1 (de) Verfahren von dna-impfung
DE69924826T8 (de) Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
DE60132190D1 (de) Mutierte version der arginin deiminase
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
EP1536006A4 (en) CANCER-ANIMALS AND THEIR USE
WO1998011234A3 (en) Human protein kinases
HUP9902150A2 (hu) Rekombináns adenovírus vektorok humán tumor génterápiára
DE60025704D1 (de) Das goodpasture-antigen bindende protein
WO2002050111A3 (en) Isolated laminin 10
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
NO20005321L (no) Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
DE69924877D1 (en) Humanes akt-3 protein
BR0208771A (pt) Peptìdeo ou poliptìdeo isolados e seus derivados, ácido nucléico codificando o mesmo, vacina copreendendo o mesmo, ácido nucléico codificando o mesmo, vetor compreendendo o referido ácido nucléico, célula hospedeira compreendendo o referido ácido nucléico, composição farmacêutica compreendendo o referido peptìdeo ou polipeptìdeo, método para tratamento ou prevençao de câncer utilizando a referida composição farmacêutica e método para induzir ou magnificar uma resposta imunológica utilizando a referida composição farmacêutica
EP1584628A3 (en) Viral protein
WO2000065055A8 (en) Human transporter proteins
MX9709525A (es) Vacunas de virus sincicial respiratorio de acido nucleico.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application